Literature DB >> 34201795

A Randomized Trial of Precision Prevention Materials to Improve Primary and Secondary Melanoma Prevention Activities among Individuals with Limited Melanoma Risk Phenotypes.

John Charles A Lacson1, Scarlet H Doyle1, Lu Qian2, Jocelyn Del Rio1, Stephanie M Forgas1, Stella Valavanis1, Rodrigo Carvajal3, Guillermo Gonzalez-Calderon3, Youngchul Kim4, Richard G Roetzheim5, Steven K Sutton4, Susan T Vadaparampil6, Peter A Kanetsky1.   

Abstract

Inherited variation at MC1R is associated with elevated melanoma risk among non-Hispanic whites (NHWs). MC1R genetic testing may unmask previously unrecognized disease risk, especially among individuals with few melanoma phenotypic risk factors. We recruited NHW individuals with limited phenotypic risk factors from two primary care clinics in west-central Florida. Participants (n = 1134) were randomized within MC1R genotype risk group (average/higher) to receive mailed precision prevention (i.e., intervention) or generic prevention materials. Participants reported hours of weekday and weekend sun exposure, frequency of intentional outdoor tanning and sun protection behaviors, number of sunburns, indoor tanning episodes, and skin examinations at baseline, and after 6 and 12 months. Among MC1R higher-risk participants, the intervention increased the likelihood of often or always wearing a shirt with sleeves (OR = 1.49, p = 0.03) and seeking shade or using an umbrella (OR = 1.42, p = 0.046), and it decreased the number of sunburns among their young children (β = -0.13, p = 0.03). Intervention effects were not noted among MC1R average-risk participants. Moderation analyses identified intervention effects within subgroups in average-risk and higher-risk participants. Precision prevention information conveying MC1R testing results can increase the practice of some sun protection behaviors among at-risk individuals with limited melanoma risk phenotypes and may provide a cross-generational tool to counteract increasing incidence of melanoma.

Entities:  

Keywords:  MC1R; genetic testing; intervention trial; melanoma; precision prevention; prevention; public health genetics; randomized trial; sun-resistant

Year:  2021        PMID: 34201795     DOI: 10.3390/cancers13133143

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  4 in total

1.  Retention and Evaluation of Precision and Generic Prevention Materials for Melanoma: A Qualitative Study Comparing Young Adults and Adults.

Authors:  Sylvia L Crowder; Acadia W Buro; John Charles A Lacson; Youngchul Kim; Steven K Sutton; Richard G Roetzheim; Susan T Vadaparampil; Marilyn Stern; Peter A Kanetsky
Journal:  Cancer Prev Res (Phila)       Date:  2022-08-01

2.  Barriers and Facilitators for Population Genetic Screening in Healthy Populations: A Systematic Review.

Authors:  Emily C Shen; Swetha Srinivasan; Lauren E Passero; Caitlin G Allen; Madison Dixon; Kimberly Foss; Brianna Halliburton; Laura V Milko; Amelia K Smit; Rebecca Carlson; Megan C Roberts
Journal:  Front Genet       Date:  2022-07-04       Impact factor: 4.772

3.  Assessment of melanoma precision prevention materials incorporating MC1R genetic risk information.

Authors:  John Charles A Lacson; Stephanie M Forgas; Scarlet H Doyle; Lu Qian; Jocelyn Del Rio; Stella Valavanis; Rodrigo Carvajal; Guillermo Gonzalez-Calderon; Youngchul Kim; Richard G Roetzheim; Susan T Vadaparampil; Peter A Kanetsky
Journal:  Transl Behav Med       Date:  2022-05-26       Impact factor: 3.626

4.  Interest and Utility of MC1R Testing for Melanoma Risk in Dermatology Patients with a History of Nonmelanoma Skin Cancer.

Authors:  Jennifer L Hay; Erica H Lee; Stephanie N Christian; Elizabeth Schofield; Jada G Hamilton; Ciyu Yang; Bobak Hedayati; Keimya Sadeghi; Mark E Robson; Allan Halpern; Liying Zhang; Irene Orlow
Journal:  J Skin Cancer       Date:  2022-07-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.